Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

June 2, 2023

Levolta partners with Tabuk for OA therapy commercialisation in MEA region

Levolta Pharmaceuticals has entered into an exclusive licensing and distribution agreement with Tabuk Pharmaceutical for commercialising VOLT01, an investigational osteoarthritis (OA) therapy in the Middle East and Africa (MEA) region.

Levolta partners with Tabuk for OA therapy commercialisation in MEA region